This past year has been a tremendous shift for the healthcare industry.  One of the most important changes that has come out of  COVID  has been the acceleration of digital health. Not only has this been beneficial for use during the pandemic, but it has also demonstrated viability for people living in remote or rural areas where traditional care is not as easily accessible to them.  Pharmaceutical companies were no exception in having to strengthen their use of digital health products and services to reach their clients directly. On this week's episode, Rob Havasy speaks with Jim Parshall, Director of Connected Health External Innovation at Eli Lilly and Company on the ways pharma has shifted focus to digital health in this post-COVID world. He speaks to the important work Eli Lilly and Company is doing to  amplify partnerships with pharma and startups and how to improve the patient experience with telehealth. The ever-evolving future of pharma looks bright but what is next?Thank you to Change Healthcare for sponsoring this episode. For more information, visit changehealthcare.com